A Novel Dual HDAC6 and Tubulin Inhibitor, MPT0B451, Displays Anti-tumor Ability in Human Cancer Cells in Vitro and in Vivo
Yi‐Wen Wu(Taipei Medical University), Wei‐Chun HuangFu(Taipei Medical University)
Cited by 31
Related Papers
A novel dual HDAC and HSP90 inhibitor, MPT0G449, downregulates oncogenic pathways in human acute leukemia in vitro and in vivo
|Oncogenesis|2021|29
Discovering a novel dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) inhibitor and its impact on tau phosphorylation and amyloid-β formation
|Journal of Enzyme Inhibition and Medicinal Chemistry|2024|7
Anti-leukemia effects of the novel synthetic 1-benzylindole derivative 21-900 in vitro and in vivo
|Scientific Reports|2017|5